Delivery Order #75N93024F00001

NIH Orders Illumina NextSeq Sequencing Reagents

The National Institutes of Health (NIH) placed a delivery order under its indefinite-delivery, indefinite-quantity (IDIQ) contract with Illumina, Inc., a genomics technology company supplying sequencing equipment and research consumables. The order covers NextSeq 1000/2000 P2 V3 reagents for 200-cycle sequencing runs, providing compatible consumables for NIH-supported genetic and biomedical research. Its scope is limited to supplying the specified reagents; no additional deliverables are identified. This order helps maintain access to materials needed for ongoing sequencing research. It was issued through the existing IDIQ rather than as a standalone competition; the record does not establish whether the parent contract was competitively awarded or sole-source, and provides no sole-source justification. The parent IDIQ covers Illumina reagents and consumables and is scheduled to run through 2025. The order’s performance period spans 2020 through early 2024. The record identifies no acquisition program, subcontractors, or other related previous contracts. It references a prior solicitation with performance standards for Illumina products but does not provide the solicitation number or further requirements.

Description

ILLUMINA NEXTSEQ 1000/2000 P2 REAGENTS (200 CYCLES) V3

View original record